Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1557067 | 1.00 | ACE2 (0.50) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL3097384 | 1.00 | ACE2 (0.50) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL8884578 | 1.00 | ACE2 (0.50) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL1557005 | 0.97 | — | — | |
| SCHEMBL1110061 | 0.92 | ACE2 (0.54) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL3090796 | 0.88 | — | — | |
| SCHEMBL20506755 | 0.85 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL21086628 | 0.85 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL22129693 | 0.85 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL20506768 | 0.85 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1971664-B1 | EMITTING MATERIALS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEMICAL LTD (KR) | 2015-09-09 | — | — | EP | disclosed |
| US-7919196-B2 | Emitting materials and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2011-04-05 | — | — | US | disclosed |
| US-7604874-B2 | Organic compounds for electroluminescence and organic electroluminescent devices using the same | LG CHEM, LTD. (KR) | 2009-10-20 | — | — | US | disclosed |
| US-7485733-B2 | Organic compounds for electroluminescence and organic electroluminescent devices using the same | LG CHEM, LTD. (KR) | 2009-02-03 | — | — | US | disclosed |
| US-20090021149-A1 | Emitting Materials and Organic Light Emitting Device Using the Same | LG CHEM. LTD. (KR) | 2009-01-22 | — | — | US | disclosed |
| EP-1971664-A1 | EMITTING MATERIALS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG Chem, Ltd. (KR) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007081179-A1 | EMITTING MATERIALS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM. LTD. (KR) | 2007-07-19 | — | — | WO | disclosed |
| US-20070037012-A1 | having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle | LG CHEM, LTD. (KR) | 2007-02-15 | — | — | US | disclosed |
| EP-1501821-A1 | NEW ORGANIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | LG Chem, Ltd. (KR) | 2005-02-02 | — | — | EP | disclosed |
| US-20040067387-A1 | Organic compounds for electroluminescence and organic electroluminescent devices using the same | LG CHEM. LTD. (KR) | 2004-04-08 | — | — | US | disclosed |
| WO-2003095445-A1 | NEW ORGANIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | LG CHEM, LTD. (KR) | 2003-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090021149-A1 | Emitting Materials and Organic Light Emitting Device Using the Same | CRY1, CRY2, PER2 | ACE2 1315/4885OPRM1 447/4885TSHR 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.